---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-028003"
form_type: "8-K"
ticker: "CTXR"
cik: "0001506251"
company_name: "Citius Pharmaceuticals, Inc."
filed_at: "2025-04-02T23:59:59+00:00"
generated_at: "2026-05-23T23:33:56.419006+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Citius Pharma raises $2M in registered direct offering; proceeds for LYMPHIR launch

## Summary
- Offering of 465,000 shares at $1.15 and 1,274,131 pre-funded warrants at $1.1499.
- Net proceeds ~$1.735M after fees; used for commercial launch of LYMPHIR and general corporate purposes.
- Placement agent H.C. Wainwright received 7% cash fee and 121,739 warrants exercisable at $1.4375.
- Company agreed to 30-day lock-up on further equity issuances.

## SEC filing metadata
- accession: 0001213900-25-028003
- form_type: 8-K
- ticker: CTXR
- cik: 0001506251
- company_name: Citius Pharmaceuticals, Inc.
- filed_at: 2025-04-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506251/000121390025028003/0001213900-25-028003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506251/000121390025028003/ea0236661-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-028003
- JSON: https://secwatch.observer/filing/0001213900-25-028003.json
- Plain text: https://secwatch.observer/filing/0001213900-25-028003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.